2023. April 11.

LAFARGE is present under the name HOLCIM on the Hungarian market since May

LAFARGE is present under the name HOLCIM on the Hungarian market since May

As of May 1, 2023, joining the new identity of the international corporate group, the company changes its name and image and continues its activities under the name Holcim Magyarország Kft.

“The name and image change expresses and further strengthens our shared value system with the global parent company, the Holcim Group, and our commitment to long-term sustainable and environmentally conscious construction solutions. Our company’s strategic goals and the high quality of its products will continue to represent the same value in the future: as the driving force of the circular economy, we intend to become the green engine of the domestic construction industry by producing sustainable and environmentally conscious cement products.”

Read more in Hungarian: article, press release

2023. March 29.

Fewer women are being screened since the epidemic – A Hungarian company gives a day off for screening

Every year in our country, we lose about two thousand women to breast cancer, and almost five hundred to cervical cancer – even though we know that early diagnosis and modern therapies greatly improve the chances of recovery. Roche Hungary has therefore announced a broad collaboration in the healthcare sector and among other large companies in order to increase the number of screening tests in health areas affecting women, which had decreased due to the coronavirus.

2023. March 13.

Sharity success at the Hungarian Business Awards

Following last year’s international recognition of the World Summit Award (WSA 2022 – Best digital solution – Hungary), our member, Sharity Zrt. received another prestigious award this year. The company received the  ‘Digital Innovation Grand Prix’ in the Hungarian Business Award event in Párisi Udvar Hotel on 9 March. Furthermore, Farkas Barsony, President & CEO of the company was recognised as the ‘Business personality of the Year’. Sharity Impact on one hand, is an innovative, pioneer digital platform for impact marketing/advertising (in and out of the Sharity app). On the other hand, a digital solution which helps simple and transparent giving and also provides the option to donate money without money by simply watching a short, educative video/ad.

2023. February 14.

CMS Emerging Europe M&A Report 2022/23

The findings from the latest CMS Emerging Europe M&A Report show that M&A activity in the region maintains a steady pace, though deal values were notably lower, and there were variations across territories and sectors. While 2022 brought a unique set of challenges, dealmaking largely compared favourably to pre-pandemic levels. M&A players showed that they can readily adapt to the new circumstances and, although they are more cautious in pursuing targets, M&A activity remains robust. Counterintuitively, in some countries geopolitical tensions have led to higher deal activity, as our roundup of countries’ performances in the report shows.
 
The key findings of the CMS Emerging Europe M&A Report include the following:

• M&A activity across Emerging Europe rose by 5.6% in volume to 1,229 deals, as compared to 2021. In contrast, the total deal value fell by 20%, to EUR 32.93bn
• Cross-border deal activity was a strongpoint, up from 743 to 815 deals, although values fell from EUR 38.2bn to EUR 22.7bn
• PE equity volumes edged up to a five-year high of 289 but values at the lowest in five years
• Poland saw the highest volumes and deal value hit a decade high of EUR 15.97bn. Romania saw the second highest volume,
• The United States continues to be the most active foreign country, with 126 deals in 2022.

Full report

2022. November 30.

Boom and Gloom? European M&A Outlook 2023

This is a comprehensive assessment of dealmaking sentiment in Europe’s M&A market, published by CMS in association with Mergermarket.

This tenth edition reflects the opinions of 330 corporates and PE firms based in Europe, the Americas and APAC, about their expectations for European M&A in the year ahead.

Highlights, video

Download report in PDF

2022. November 30.

Novartis to spend $300m on biotherapeutics drive

Swiss pharmaceutical company Novartis is investing $300 million ($288 million) in biotherapeutics development, which includes a new $100 million biologics hub at its home base in Basel.

Read more

2022. September 07.

ABB launches its fastest five-axis delta robot for picking, packaging and positioning of light products

The IRB 365 can be used in a wide range of applications, such as, product positioning, top loading, secondary (or collection) packaging, handling and sorting of bottles, 3D picking, dispensing and package sorting. Powered by the OmniCoreTM C30 controller – currently the standard controller for the smallest delta robots on the market – the system offers best-in-class motion control, built-in digital connectivity and over 1,000 additional software/hardware features ready to meet future needs and requirements.

Read more

2022. September 07.

Doktor 24: after the two-billion bond issue, private insurance will also start

On the Budapest Stock Exchange (BÉT), Doktor24 is the first private healthcare provider whose securities can be traded publicly from today, after issuing a high-value bond in the spring. The goal of the founding owners is to have their shares on the stock market in a few years. From September 2022, their private health insurance will also start.

Read more